Dabigatran etexilate Completed Phase 4 Trials for Nonvalvular Atrial Fibrillation Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02348723Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)
NCT01468155DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation
NCT01339819Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
NCT01896297Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function